Inventor · disambiguated record
Stanley J. Hollenbach
Also filed as: HOLLENBACH STANLEY J
5 granted patents·12 pending applications·36 citations·filing 2007–2024
79Inventor score
Files withPORTOLA PHARM INC6ALEXION PHARMA INC3SINHA UMA3MILLENNIUM PHARM INC2KINESID THERAPEUTICS INC1
Top patents by PatentIndex Score
17 records- 0192US9056106B2Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the sameSINHA UMA·Filed 2010·Granted Jun 16, 2015·20 cites·8 claims
- 0290US10765726B2Unit dose formulation of antidotes for factor Xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2017·Granted Sep 8, 2020·3 cites·20 claims
- 0388US2025186563A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2024·Application pending·0 cites
- 0485US8404724B2Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitorSINHA UMA·Filed 2007·Granted Mar 26, 2013·9 cites·5 claims
- 0585US2024189401A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2023·Application pending·0 cites
- 0678US8455440B2Combination anticoagulant therapy with a compound that acts as a factor Xa inhibitorSINHA UMA·Filed 2011·Granted Jun 4, 2013·3 cites·24 claims
- 0777US2023000957A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the sameALEXION PHARMA INC·Filed 2022·Application pending·0 cites
- 0876US10912743B2Compositions for treating inflammation and methods of treating the sameNOVAN INC·Filed 2017·Granted Feb 9, 2021·1 cites·18 claims
- 0971US2021085762A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2020·Application pending·0 cites
- 1066US2020129597A1MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTEPORTOLA PHARM INC·Filed 2019·Application pending·0 cites
- 1165US2017014492A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2016·Application pending·0 cites
- 1263US2015025011A1Unit dose formulation of antidotes for factor xa inhibitors and methods of using the samePORTOLA PHARM INC·Filed 2014·Application pending·0 cites
- 1361US2016015793A1Modulation of factor xa inhibitor mediated blood loss by partial and transient administration of antidotePORTOLA PHARMACUETICALS INC·Filed 2013·Application pending·0 cites
- 1461US2018185459A1MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTEPORTOLA PHARM INC·Filed 2018·Application pending·0 cites
- 1560US2008254036A1Combination anticoagulant therapy with a compound that acts as a factor xa inhibitorMILLENNIUM PHARM INC·Filed 2008·Application pending·0 cites
- 1654US2013315897A1Combination Anticoagulant Therapy With A Compound That Acts As A Factor Xa InhibitorMILLENNIUM PHARM INC·Filed 2013·Application pending·0 cites
- 1750US2024018105A1Tropolone derivatives and tautomers thereof for iron regulation in animalsKINESID THERAPEUTICS INC·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Stanley J. Hollenbach files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →